2 buy-rated ASX healthcare shares

ResMed Inc. (ASX:RMD) and this ASX healthcare shares have been given buy ratings. Here's why they could be shares to own…

| More on:
Rising healthcare ASX share price represented by doctor giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare sector has been a great place to invest over the last few years. Thanks to increasing demand due to a number of industry tailwinds, this side of the market has flourished.

The good news is that demand continues to increase and looks unlikely to stop doing so for some time to come. This could make the sector a great place to invest with a long term view.

But which ASX healthcare shares should you buy? Two to consider are listed below:

Ramsay Health Care Limited (ASX: RHC)

Few companies will benefit from increasing demand for healthcare services more than Ramsay Health Care. It is a leading private healthcare company with operations across the world.

While the pandemic led to a significant drop in elective surgeries, trading conditions have been improving greatly. As a result, Ramsay looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

In addition to this, the company has a long history of accelerating its growth through acquisitions. And given its strong balance sheet, it wouldn't be overly surprising to see the company make another purchase in the near term.

One broker that is a fan of Ramsay is Macquarie. Its analysts have an outperform rating and $75.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another quality healthcare share to look at is ResMed. It is one of the world's leading sleep treatment-focused medical device companies.

Thanks to its industry-leading products, growing software business, the increasing awareness of sleep disorders, and its investment in R&D, ResMed has been growing at a consistently strong rate for a number of years.

Positively, the company still has a long runway for growth. This is thanks to its huge addressable market and the shift to home healthcare. The latter is being supported by its comprehensive out-of-hospital software platforms.

Morgans is bullish on ResMed. It currently has an add rating and $30.09 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Can this biotech giant deliver healthy returns?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

UP 127% in a year, why is the Pro Medicus share price rocketing higher again today?

ASX investors are sending Pro Medicus shares flying higher on Thursday. But why?

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Healthcare Shares

These healthcare stocks could be set to double according to broker

Interested in gaining exposure to the healthcare sector? These options could be ones to watch. 

Read more »

Shot of two young scientists using a laptop in a laboratory.
Healthcare Shares

Up 250% in a year, how much higher can this ASX healthcare share climb?  

The future looks promising for this biotech firm after delivering a record-quarterly result.

Read more »

shadow of a man looking out a window with arrows signifying falling share price
Healthcare Shares

Macquarie expects this ASX All Ords healthcare stock to fall 21% in FY26

The company faces several headwinds across multiple divisions.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Top broker names the best ASX healthcare shares to buy in FY26

Bell Potter has good things to say about these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Which ASX All Ords stock is jumping on record quarter?

This stock reported record sales during the past three months.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 36% in a year, why this $8 billion ASX 200 stock has still a 'strong growth forecast'

If you haven’t heard of this fast-rising ASX 200 stock yet, that’s about to change.

Read more »